Probiotic Spores of Shouchella clausii SF174 and Displayed Bromelain Show Beneficial Additive Potential
- PMID: 39940711
- PMCID: PMC11817855
- DOI: 10.3390/ijms26030942
Probiotic Spores of Shouchella clausii SF174 and Displayed Bromelain Show Beneficial Additive Potential
Abstract
Probiotics have health-beneficial properties mainly due to either a direct action on the host or the modulation of the host microbiota. Health-beneficial properties have also been associated with a variety of plant-derived molecules, widely used as dietary supplements. This study explores the possibility of combining the actions of probiotics and of plant-derived molecules by developing beneficial, probiotic-carrying, heterologous molecules. To this extent, spores of SF174, a well-characterized probiotic strain of Shouchella clausii (formerly Bacillus clausii), were used to bind bromelain, a plant-derived mixture of endopeptidases with beneficial effects. Probiotic spores displaying bromelain maintained their antioxidant activity and acquired the endopeptidase activity of the heterologous molecule. The endopeptidase activity was stabilized by the interaction with the spore and largely preserved from degradation at simulated gastric conditions. Under conditions mimicking those encountered in the intestine, as well as upon spore germination, active bromelain was released from the spore surface. The in vitro results reported in this study support the idea that probiotics carrying beneficial heterologous molecules combine the health properties of the probiotic with those of the delivered molecule and pave the way for the development of a novel class of functional probiotics.
Keywords: Bacillus clausii; antioxidants; beneficial bacteria; functional probiotics; surface display.
Conflict of interest statement
Some of the authors (R.C. and V.B.) are employees of Gruppo Savio. Of the authors not employed by Gruppo Savio, E.R. acts as a consultant for Gruppo Savio, which has the rights for the commercialization of strain SF174.
Figures







References
-
- Hungin A.P.S., Mitchell C.R., Whorwell P., Mulligan C., Cole O., Agreus L., Fracasso P., Lionis C., Mendive J., Philippart de Foy J.-M., et al. Systematic review: Probiotics in the management of lower gastrointestinal symptoms—An updated evidence-based international consensus. Aliment. Pharmacol. Ther. 2018;47:1054–1070. doi: 10.1111/apt.14539. for the European Society for Primary Care Gastroenterology. - DOI - PMC - PubMed
-
- Costa F.F., Dias T.G., Mendes P.M., Viana J.P.M., Madeira E.B., Pereira A.L.F., Ferreira A.G.N., Neto M.S., Dutra R.P., Reis A.S., et al. Antioxidant and antimicrobial properties of probiotics: Insights from in vitro assays. Probiotics Antimicrob. Proteins. 2024 doi: 10.1007/s12602-024-10426-w. - DOI - PubMed
-
- Wang D., Xu R., Liu S., Sun X., Zhang T., Shi L., Wang Y. Enhancing the application of probiotics in probiotic food products from the perspective of improving stress resistance by regulating cell physiological function: A review. Food Res. Int. 2025;199:115369. doi: 10.1016/j.foodres.2024.115369. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources